Transcatheter Pacing System Market By Application (Atrial Fibrillation and Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Others); By End Users (Hospitals & Clinics, Ambulatory Surgical Centers); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
A leadless pacemaker is a novel concept that involves a small pacing device that can be self-contained within the heart. When compared to transvenous cardiac pacemakers, new research shows that transcatheter pacemakers are associated with a lower incidence of significant problems. This appears to be especially important in children and young people, who may face a variety of problems throughout their lives. Transvenous cardiac pacemakers increases quality of life and lowers mortality, but they are linked to a number of short- and long-term problems, primarily due to the presence of transvenous leads and the pulse generator. Despite significant advancements in pacing technology over decades, traditional cardiac pacemakers are still associated with a variety of short- and long-term problems, the majority of which are connected to transvenous leads. Thus, transcatheter pacemakers are largely adopted, not only to increase quality of life, but also because of lower mortality rates. Hence, the potential beneficial characteristics is favouring the growth of global transcatheter pacing system market.
Clinical trials have already investigated the safety and clinical performance of transcatheter leadless pacemakers. Clinical trial experience with the Micra Transcatheter Pacing System (Medtronic) began in 2013, wherein it received CE mark in April 2015 and FDA approval in April 2016. According to the published data, the implant success rate of Micra in adults is around 99 percent, and the device has also replaced significant problems of conventional pacemakers. Leadless pacemakers have proven promise in terms of potentially lowering transvenous system problems. Though traditional transvenous pacing is currently the standard of therapy, technological advancements can enable this form of cardiac pacing to benefit more patients.
Global transcatheter pacing system market is anticipated to witness a CAGR of 15.1% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Transcatheter Pacing System Market Revenue & Forecast, (US$ Million), 2015 – 2029
Application Outlook
Based on the application segment, the global transcatheter pacing system market is segmented into atrial fibrillation and bradycardia, atrioventricular block, sinus node dysfunction and others. Atrioventricular Block held the highest share in the application segment in the year 2020. Atrioventricular (AV) block occurs when electrical transmission from the atria to the ventricles is interrupted or delayed due to anomalies in the AV node's conduction pathway. The atrioventricular block has three types namely first degree, second degree and third degree. According to the studies, the prelevance of first degree atrioventricular block in the general population is greater than the other types. Thus, with the rising prelevance of these AV blocks, the transcatheter pacemaker implantations are becoming more common as a treatment for atrioventricular (AV) block around the world. The most common reason for pacemaker installation is atrioventricular block (AVB). AVB has a favourable prognosis when it is not accompanied by other cardiac disorders, with survival rates comparable to the general population. Moreover, in the recent study of transcatheter pacemakers, researchers found out that patients with atrioventricular block implanted with transcatheter pacemakers experienced improvements in atrioventricular synchrony and stroke volume when they had been under algorithm-based atrioventricular synchronous pacing compared to VVI pacing. Thus, transcatheter pacemakers are highly being adopted for the treatments of atrioventricular block and other cardiology applications.
End Users Outlook
Based on end users, the global transcatheter pacing system market is segmented into hospitals and clinics, and ambulatory surgical centers. Ambulatory surgical centers is anticipated to be the fastest growing segment during the forecast years. In the last few years, the demand for ambulatory surgical centers has increased as it has proven to be a modern medical facility providing same-day surgical care and procedures which do not require hospital admissions. In 2019, when Centers for Medicare & Medicaid Services (CMS) reimbursement plan for cardiovascular operations allowed more cardiovascular treatments for ambulatory surgical centres (ASC), the administrators and physicians were required to work together to preserve market share and meet specified cardiovascular services. In the initial years, pacemaker implant surgery was considered to be a difficult procedure that was performed through cardiovascular surgery and the patients were required to spend several days in the hospital. As there have been numerous advancements in the surgical processes, the transcatheter pacemakers implant surgery is risen along with advancements in ambulatory surgical centers. Thus, with the advancements and support of experienced surgeons, the ambulatory surgical centers are anticipated to witness fastest growth in the global transcatheter pacing system market.
Region Outlook
Based on the region, North America held the highest share in the global transcatheter pacing system market in 2020. According to the data published by Centers for Disease Control and Prevention (CDC), about 647,000 Americans die each year from heart disease, and heart disease remains the leading cause of death in the United States, nationally. In the last few years, the cardiology healthcare sector has experienced huge investments to introduce advanced treatments and equipment for cardiology. In April 2016, the U.S. Food and Drug Administration approved the first leadless pacemaker to provide an electrical connection between the pulse-generating device and the heart. The latest pacemakers’ offers new option for patients which may help prevent problems associated with the wired leads. Thus such advancements are boosting the growth of transcatheter pacing system market in the region.
Competitive Landscape
The report provides both, qualitative and quantitative research of transcatheter pacing system market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The key market participants operating in the global transcatheter pacing system market are:
- Abbott
- Boston Scientific Corporation
- Medtronic
- Other Market Participants
Global Transcatheter Pacing System Market:
- By Application
- Atrial Fibrillation and Bradycardia
- Atrioventricular Block
- Sinus Node Dysfunction
- Others
- By End Users
- Hospitals & Clinics
- Ambulatory Surgical Centers
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Transcatheter Pacing System Market
6. Market Synopsis:
Transcatheter Pacing System Market
7. Transcatheter Pacing System Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Transcatheter Pacing System Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Transcatheter Pacing System Market
7.6. Porter’s
Five Force Analysis
8. Global Transcatheter Pacing System Market Analysis and
Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global
Transcatheter Pacing System Market Revenue (US$ Mn)
8.2. Global
Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Application
8.2.1. Atrial
Fibrillation and Bradycardia
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Atrioventricular
Block
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.2.3. Sinus
Node Dysfunction
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2020
8.2.3.3. Market Forecast, 2021 - 2029
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2020
8.2.3.5.1.2. Market
Forecast, 2021 - 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2020
8.2.3.5.2.2. Market
Forecast, 2021 - 2029
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2020
8.2.3.5.3.2. Market
Forecast, 2021 - 2029
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2020
8.2.3.5.4.2. Market
Forecast, 2021 - 2029
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2020
8.2.3.5.5.2. Market
Forecast, 2021 - 2029
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2020
8.2.4.3. Market Forecast, 2021 - 2029
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2020
8.2.4.5.1.2. Market
Forecast, 2021 - 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2020
8.2.4.5.2.2. Market
Forecast, 2021 - 2029
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2020
8.2.4.5.3.2. Market
Forecast, 2021 - 2029
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2020
8.2.4.5.4.2. Market
Forecast, 2021 - 2029
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2020
8.2.4.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By
Application
9. Global Transcatheter Pacing System Market Analysis and
Forecasts, 2021 – 2029
9.1. Overview
9.2. Global
Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By End Users
9.2.1. Hospitals
and Clinics
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Ambulatory
Surgical Centers
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By End
Users
10. North America Transcatheter Pacing System Market Analysis and
Forecasts, 2021 - 2029
10.1. Overview
10.1.1. North
America Transcatheter Pacing System Market Revenue (US$ Mn)
10.2. North
America Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Application
10.2.1. Atrial
Fibrillation and Bradycardia
10.2.2. Atrioventricular
Block
10.2.3. Sinus
Node Dysfunction
10.2.4. Others
10.3. North
America Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
End Users
10.3.1. Hospitals
and Clinics
10.3.2. Ambulatory
Surgical Centers
10.4. North
America Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Country
10.4.1. U.S
10.4.1.1. U.S Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
10.4.1.1.1. Atrial Fibrillation and Bradycardia
10.4.1.1.2. Atrioventricular Block
10.4.1.1.3. Sinus Node Dysfunction
10.4.1.1.4. Others
10.4.1.2. U.S Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
10.4.1.2.1. Hospitals and Clinics
10.4.1.2.2. Ambulatory Surgical Centers
10.4.2. Canada
10.4.2.1. Canada Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
10.4.2.1.1. Atrial Fibrillation and Bradycardia
10.4.2.1.2. Atrioventricular Block
10.4.2.1.3. Sinus Node Dysfunction
10.4.2.1.4. Others
10.4.2.2. Canada Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
10.4.2.2.1. Hospitals and Clinics
10.4.2.2.2. Ambulatory Surgical Centers
10.4.3. Mexico
10.4.3.1. Mexico Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
10.4.3.1.1. Atrial Fibrillation and Bradycardia
10.4.3.1.2. Atrioventricular Block
10.4.3.1.3. Sinus Node Dysfunction
10.4.3.1.4. Others
10.4.3.2. Mexico Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
10.4.3.2.1. Hospitals and Clinics
10.4.3.2.2. Ambulatory Surgical Centers
10.4.4. Rest of
North America
10.4.4.1. Rest of North America Transcatheter Pacing System Market
Revenue (US$ Mn) and Forecasts, By Application
10.4.4.1.1. Atrial Fibrillation and Bradycardia
10.4.4.1.2. Atrioventricular Block
10.4.4.1.3. Sinus Node Dysfunction
10.4.4.1.4. Others
10.4.4.2. Rest of North America Transcatheter Pacing System Market
Revenue (US$ Mn) and Forecasts, By End Users
10.4.4.2.1. Hospitals and Clinics
10.4.4.2.2. Ambulatory Surgical Centers
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Application
10.5.3. By End
Users
11. Europe Transcatheter Pacing System Market Analysis and
Forecasts, 2021 - 2029
11.1. Overview
11.1.1. Europe
Transcatheter Pacing System Market Revenue (US$ Mn)
11.2. Europe
Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Application
11.2.1. Atrial
Fibrillation and Bradycardia
11.2.2. Atrioventricular
Block
11.2.3. Sinus
Node Dysfunction
11.2.4. Others
11.3. Europe
Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By End Users
11.3.1. Hospitals
and Clinics
11.3.2. Ambulatory
Surgical Centers
11.4. Europe
Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By Country
11.4.1. France
11.4.1.1. France Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.1.1.1. Atrial Fibrillation and Bradycardia
11.4.1.1.2. Atrioventricular Block
11.4.1.1.3. Sinus Node Dysfunction
11.4.1.1.4. Others
11.4.1.2. France Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
11.4.1.2.1. Hospitals and Clinics
11.4.1.2.2. Ambulatory Surgical Centers
11.4.2. The UK
11.4.2.1. The UK Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.2.1.1. Atrial Fibrillation and Bradycardia
11.4.2.1.2. Atrioventricular Block
11.4.2.1.3. Sinus Node Dysfunction
11.4.2.1.4. Others
11.4.2.2. The UK Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
11.4.2.2.1. Hospitals and Clinics
11.4.2.2.2. Ambulatory Surgical Centers
11.4.3. Spain
11.4.3.1. Spain Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.3.1.1. Atrial Fibrillation and Bradycardia
11.4.3.1.2. Atrioventricular Block
11.4.3.1.3. Sinus Node Dysfunction
11.4.3.1.4. Others
11.4.3.2. Spain Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
11.4.3.2.1. Hospitals and Clinics
11.4.3.2.2. Ambulatory Surgical Centers
11.4.4. Germany
11.4.4.1. Germany Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By Application
11.4.4.1.1. Atrial Fibrillation and Bradycardia
11.4.4.1.2. Atrioventricular Block
11.4.4.1.3. Sinus Node Dysfunction
11.4.4.1.4. Others
11.4.4.2. Germany Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By End Users
11.4.4.2.1. Hospitals and Clinics
11.4.4.2.2. Ambulatory Surgical Centers
11.4.5. Italy
11.4.5.1. Italy Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
11.4.5.1.1. Atrial Fibrillation and Bradycardia
11.4.5.1.2. Atrioventricular Block
11.4.5.1.3. Sinus Node Dysfunction
11.4.5.1.4. Others
11.4.5.2. Italy Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
11.4.5.2.1. Hospitals and Clinics
11.4.5.2.2. Ambulatory Surgical Centers
11.4.6. Nordic
Countries
11.4.6.1. Nordic Countries Transcatheter Pacing System Market Revenue
(US$ Mn) and Forecasts, By Application
11.4.6.1.1. Atrial Fibrillation and Bradycardia
11.4.6.1.2. Atrioventricular Block
11.4.6.1.3. Sinus Node Dysfunction
11.4.6.1.4. Others
11.4.6.2. Nordic Countries Transcatheter Pacing System Market Revenue
(US$ Mn) and Forecasts, By End Users
11.4.6.2.1. Hospitals and Clinics
11.4.6.2.2. Ambulatory Surgical Centers
11.4.6.3. Nordic Countries Transcatheter Pacing System Market Revenue
(US$ Mn) and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux Union Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
11.4.7.1.1. Atrial Fibrillation and Bradycardia
11.4.7.1.2. Atrioventricular Block
11.4.7.1.3. Sinus Node Dysfunction
11.4.7.1.4. Others
11.4.7.2. Benelux Union Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By End Users
11.4.7.2.1. Hospitals and Clinics
11.4.7.2.2. Ambulatory Surgical Centers
11.4.7.3. Benelux Union Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest of Europe Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
11.4.8.1.1. Atrial Fibrillation and Bradycardia
11.4.8.1.2. Atrioventricular Block
11.4.8.1.3. Sinus Node Dysfunction
11.4.8.1.4. Others
11.4.8.2. Rest of Europe Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By End Users
11.4.8.2.1. Hospitals and Clinics
11.4.8.2.2. Ambulatory Surgical Centers
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Application
11.5.3. By End
Users
12. Asia Pacific Transcatheter Pacing System Market Analysis and
Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Asia
Pacific Transcatheter Pacing System Market Revenue (US$ Mn)
12.2. Asia
Pacific Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Application
12.2.1. Atrial
Fibrillation and Bradycardia
12.2.2. Atrioventricular
Block
12.2.3. Sinus
Node Dysfunction
12.2.4. Others
12.3. Asia
Pacific Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
End Users
12.3.1. Hospitals
and Clinics
12.3.2. Ambulatory
Surgical Centers
12.4. Asia
Pacific Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Country
12.4.1. China
12.4.1.1. China Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.1.1.1. Atrial Fibrillation and Bradycardia
12.4.1.1.2. Atrioventricular Block
12.4.1.1.3. Sinus Node Dysfunction
12.4.1.1.4. Others
12.4.1.2. China Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
12.4.1.2.1. Hospitals and Clinics
12.4.1.2.2. Ambulatory Surgical Centers
12.4.2. Japan
12.4.2.1. Japan Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.2.1.1. Atrial Fibrillation and Bradycardia
12.4.2.1.2. Atrioventricular Block
12.4.2.1.3. Sinus Node Dysfunction
12.4.2.1.4. Others
12.4.2.2. Japan Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
12.4.2.2.1. Hospitals and Clinics
12.4.2.2.2. Ambulatory Surgical Centers
12.4.3. India
12.4.3.1. India Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
12.4.3.1.1. Atrial Fibrillation and Bradycardia
12.4.3.1.2. Atrioventricular Block
12.4.3.1.3. Sinus Node Dysfunction
12.4.3.1.4. Others
12.4.3.2. India Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
12.4.3.2.1. Hospitals and Clinics
12.4.3.2.2. Ambulatory Surgical Centers
12.4.4. New
Zealand
12.4.4.1. New Zealand Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
12.4.4.1.1. Atrial Fibrillation and Bradycardia
12.4.4.1.2. Atrioventricular Block
12.4.4.1.3. Sinus Node Dysfunction
12.4.4.1.4. Others
12.4.4.2. New Zealand Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By End Users
12.4.4.2.1. Hospitals and Clinics
12.4.4.2.2. Ambulatory Surgical Centers
12.4.5. Australia
12.4.5.1. Australia Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By Application
12.4.5.1.1. Atrial Fibrillation and Bradycardia
12.4.5.1.2. Atrioventricular Block
12.4.5.1.3. Sinus Node Dysfunction
12.4.5.1.4. Others
12.4.5.2. Australia Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By End Users
12.4.5.2.1. Hospitals and Clinics
12.4.5.2.2. Ambulatory Surgical Centers
12.4.6. South
Korea
12.4.6.1. South Korea Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
12.4.6.1.1. Atrial Fibrillation and Bradycardia
12.4.6.1.2. Atrioventricular Block
12.4.6.1.3. Sinus Node Dysfunction
12.4.6.1.4. Others
12.4.6.2. South Korea Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By End Users
12.4.6.2.1. Hospitals and Clinics
12.4.6.2.2. Ambulatory Surgical Centers
12.4.7. Southeast
Asia
12.4.7.1. Southeast Asia Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
12.4.7.1.1. Atrial Fibrillation and Bradycardia
12.4.7.1.2. Atrioventricular Block
12.4.7.1.3. Sinus Node Dysfunction
12.4.7.1.4. Others
12.4.7.2. Southeast Asia Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By End Users
12.4.7.2.1. Hospitals and Clinics
12.4.7.2.2. Ambulatory Surgical Centers
12.4.7.3. Southeast Asia Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest of Asia Pacific Transcatheter Pacing System Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.8.1.1. Atrial Fibrillation and Bradycardia
12.4.8.1.2. Atrioventricular Block
12.4.8.1.3. Sinus Node Dysfunction
12.4.8.1.4. Others
12.4.8.2. Rest of Asia Pacific Transcatheter Pacing System Market
Revenue (US$ Mn) and Forecasts, By End Users
12.4.8.2.1. Hospitals and Clinics
12.4.8.2.2. Ambulatory Surgical Centers
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Application
12.5.3. By End
Users
13. Middle East and Africa Transcatheter Pacing System Market
Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Middle
East and Africa Transcatheter Pacing System Market Revenue (US$ Mn)
13.2. Middle
East and Africa Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
13.2.1. Atrial
Fibrillation and Bradycardia
13.2.2. Atrioventricular
Block
13.2.3. Sinus
Node Dysfunction
13.2.4. Others
13.3. Middle
East and Africa Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
13.3.1. Hospitals
and Clinics
13.3.2. Ambulatory
Surgical Centers
13.4. Middle
East and Africa Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi Arabia Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
13.4.1.1.1. Atrial Fibrillation and Bradycardia
13.4.1.1.2. Atrioventricular Block
13.4.1.1.3. Sinus Node Dysfunction
13.4.1.1.4. Others
13.4.1.2. Saudi Arabia Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By End Users
13.4.1.2.1. Hospitals and Clinics
13.4.1.2.2. Ambulatory Surgical Centers
13.4.2. UAE
13.4.2.1. UAE Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.2.1.1. Atrial Fibrillation and Bradycardia
13.4.2.1.2. Atrioventricular Block
13.4.2.1.3. Sinus Node Dysfunction
13.4.2.1.4. Others
13.4.2.2. UAE Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
13.4.2.2.1. Hospitals and Clinics
13.4.2.2.2. Ambulatory Surgical Centers
13.4.3. Egypt
13.4.3.1. Egypt Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.3.1.1. Atrial Fibrillation and Bradycardia
13.4.3.1.2. Atrioventricular Block
13.4.3.1.3. Sinus Node Dysfunction
13.4.3.1.4. Others
13.4.3.2. Egypt Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
13.4.3.2.1. Hospitals and Clinics
13.4.3.2.2. Ambulatory Surgical Centers
13.4.4. Kuwait
13.4.4.1. Kuwait Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
13.4.4.1.1. Atrial Fibrillation and Bradycardia
13.4.4.1.2. Atrioventricular Block
13.4.4.1.3. Sinus Node Dysfunction
13.4.4.1.4. Others
13.4.4.2. Kuwait Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
13.4.4.2.1. Hospitals and Clinics
13.4.4.2.2. Ambulatory Surgical Centers
13.4.5. South
Africa
13.4.5.1. South Africa Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By Application
13.4.5.1.1. Atrial Fibrillation and Bradycardia
13.4.5.1.2. Atrioventricular Block
13.4.5.1.3. Sinus Node Dysfunction
13.4.5.1.4. Others
13.4.5.2. South Africa Transcatheter Pacing System Market Revenue (US$
Mn) and Forecasts, By End Users
13.4.5.2.1. Hospitals and Clinics
13.4.5.2.2. Ambulatory Surgical Centers
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest of Middle East & Africa Transcatheter Pacing System
Market Revenue (US$ Mn) and Forecasts, By Application
13.4.6.1.1. Atrial Fibrillation and Bradycardia
13.4.6.1.2. Atrioventricular Block
13.4.6.1.3. Sinus Node Dysfunction
13.4.6.1.4. Others
13.4.6.2. Rest of Middle East & Africa Transcatheter Pacing System
Market Revenue (US$ Mn) and Forecasts, By End Users
13.4.6.2.1. Hospitals and Clinics
13.4.6.2.2. Ambulatory Surgical Centers
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Application
13.5.3. By End
Users
14. Latin America Transcatheter Pacing System Market Analysis and
Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Latin
America Transcatheter Pacing System Market Revenue (US$ Mn)
14.2. Latin
America Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Application
14.2.1. Atrial
Fibrillation and Bradycardia
14.2.2. Atrioventricular
Block
14.2.3. Sinus
Node Dysfunction
14.2.4. Others
14.3. Latin
America Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
End Users
14.3.1. Hospitals
and Clinics
14.3.2. Ambulatory
Surgical Centers
14.4. Latin
America Transcatheter Pacing System Market Revenue (US$ Mn) and Forecasts, By
Country
14.4.1. Brazil
14.4.1.1. Brazil Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By Application
14.4.1.1.1. Atrial Fibrillation and Bradycardia
14.4.1.1.2. Atrioventricular Block
14.4.1.1.3. Sinus Node Dysfunction
14.4.1.1.4. Others
14.4.1.2. Brazil Transcatheter Pacing System Market Revenue (US$ Mn) and
Forecasts, By End Users
14.4.1.2.1. Hospitals and Clinics
14.4.1.2.2. Ambulatory Surgical Centers
14.4.2. Argentina
14.4.2.1. Argentina Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By Application
14.4.2.1.1. Atrial Fibrillation and Bradycardia
14.4.2.1.2. Atrioventricular Block
14.4.2.1.3. Sinus Node Dysfunction
14.4.2.1.4. Others
14.4.2.2. Argentina Transcatheter Pacing System Market Revenue (US$ Mn)
and Forecasts, By End Users
14.4.2.2.1. Hospitals and Clinics
14.4.2.2.2. Ambulatory Surgical Centers
14.4.3. Rest of
Latin America
14.4.3.1. Rest of Latin America Transcatheter Pacing System Market
Revenue (US$ Mn) and Forecasts, By Application
14.4.3.1.1. Atrial Fibrillation and Bradycardia
14.4.3.1.2. Atrioventricular Block
14.4.3.1.3. Sinus Node Dysfunction
14.4.3.1.4. Others
14.4.3.2. Rest of Latin America Transcatheter Pacing System Market
Revenue (US$ Mn) and Forecasts, By End Users
14.4.3.2.1. Hospitals and Clinics
14.4.3.2.2. Ambulatory Surgical Centers
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By
Application
14.5.3. By End
Users
15. Competitive Benchmarking
15.1. Market
Share Analysis, 2020
15.2. Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16. Player Profiles
16.1. Abbott
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Boston
Scientific Corporation
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Medtronic
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. Other
Market Participants
17. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.